Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-22 Option Award | 2023-06-26 7:47 pm | N/A 2033-06-22 | ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director | 25,850 | $0 | 25,850 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:01 pm | N/A 2033-06-14 | Avidity Biosciences Inc. | RNA | BOESS CARSTEN Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 8:44 pm | N/A 2032-06-14 | Avidity Biosciences Inc. | RNA | BOESS CARSTEN Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director | 47,745 | $0 | 47,745 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-16 8:07 pm | N/A 2031-06-14 | ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director | 12,236 | $0 | 12,236 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-16 7:59 pm | N/A 2031-06-15 | Avidity Biosciences Inc. | RNA | BOESS CARSTEN Director | 15,000 | $0 | 15,000 (Direct) | View |
Ownership(A) | 2020-08-10 10:41 am | N/A N/A | Health Sciences Acquisitions Corp 2 | HSAQ | BOESS CARSTEN Director | 0 | $0 | 22,261 (Direct) | View |
Ownership | 2020-08-03 8:54 pm | N/A N/A | Health Sciences Acquisitions Corp 2 | HSAQ | BOESS CARSTEN Director | 0 | $0 | 20,261 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 9:38 pm | N/A 2030-06-16 | ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2020-06-11 8:14 pm | N/A 2030-05-14 | Avidity Biosciences Inc. | RNA | BOESS CARSTEN Director | 0 | $0 | 20,858 (Direct) | View |